- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
May 3rd, 2007
Ron Zuckermann, lead scientist for Lawrence Berkeley National Lab's Molecular Foundry Biological Nanostructures Facility, is taking the same techniques drug companies use to discover drugs to help nanoscientists cut the cost and shorten the time for their hunt for useful nano-compounds.
Dr. Zuckermann knows a lot about that proven drug-discovery process, dubbed combinatorial chemistry - he helped invent the process more than a decade ago. Before coming to the Molecular Foundry, Dr. Zuckermann worked for the biotechnology industry, and was one of the creators of the combinatorial chemistry techniques, whereby researchers create and test thousands (and in some cases millions) of compounds for just the right properties. His current LBNL work is sponsored by the Department of Energy, and is available for universities and private research arms to participate in.
|Related News Press|
Exploring phosphorene, a promising new material April 29th, 2016
Atomic magnets using hydrogen and graphene April 27th, 2016
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Nanoparticles present sustainable way to grow food crops May 1st, 2016
Searching for a nanotech self-organizing principle May 1st, 2016
Personal cooling units on the horizon April 29th, 2016